Atomoxetine, Placebo and Parent Management Training in Autism

Clinical trial NCT00844753 · COMPLETED

Trial details

NCT number: NCT00844753
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Autism Pervasive Development Disorder Asperger's Disorder Attention Deficit Hyperactivity Disorder

Start date: 2008-10-01
Primary completion: 2014-04-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.